Federated Hermes
SGMO

Federated Hermes’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Federated Hermes’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-335,119
Closed -$120K – 2153
2024
Q2 		$120K Hold
335,119
– – ﹤0.01% 1548
2024
Q1 		$225K Sell
335,119
-5,574
-2% -$4.04K ﹤0.01% 1473
2023
Q4 		$185K Sell
340,693
-103,255
-23% -$47.6K ﹤0.01% 1523
2023
Q3 		$266K Buy
443,948
+3,013
+0.7% +$3.23K ﹤0.01% 1482
2023
Q2 		$573K Buy
440,935
+120,899
+38% +$165K ﹤0.01% 1325
2023
Q1 		$563K Buy
320,036
+178,507
+126% +$509K ﹤0.01% 1369
2022
Q4 		$444K Sell
141,529
-192,256
-58% -$746K ﹤0.01% 1398
2022
Q3 		$1.64M Sell
333,785
-395,565
-54% -$2.03M ﹤0.01% 972
2022
Q2 		$3.02M Sell
729,350
-354,854
-33% -$1.53M 0.01% 818
2022
Q1 		$6.3M Buy
1,084,204
+599,932
+124% +$3.57M 0.01% 723
2021
Q4 		$3.63M Buy
484,272
+476,288
+5,966% +$4.14M 0.01% 909
2021
Q3 		$72K Buy
+7,984
New +$78.9K ﹤0.01% 1816
2018
Q3 		– Sell
-1,387
Closed -$19K – 2319
2018
Q2 		$19K Sell
1,387
-425,435
-100% -$7.07M ﹤0.01% 1809
2018
Q1 		$8.11M Buy
426,822
+134,389
+46% +$2.87M 0.02% 488
2017
Q4 		$4.8M Buy
292,433
+115,639
+65% +$1.72M 0.01% 627
2017
Q3 		$2.65M Buy
176,794
+28,583
+19% +$316K 0.01% 796
2017
Q2 		$1.3M Buy
+148,211
New +$951K ﹤0.01% 1118
2016
Q1 		– Sell
-18,162
Closed -$166K – 2165
2015
Q4 		$166K Buy
+18,162
New +$140K ﹤0.01% 1505

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Federated Hermes's SGMO Position: Q3 2024 in Review

Federated Hermes sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 335,119 shares — an estimated $120K sold.

Federated Hermes first reported a position in SGMO in Q4 2015 and held it in 18 quarters. The position peaked at $8.11M in Q1 2018. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • Federated Hermes reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Federated Hermes sold 335,119 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $120K.
  • Federated Hermes first reported a position in SANGAMO THERAPEUTICS INC in Q4 2015 and held it in 18 quarters.
  • Federated Hermes's SANGAMO THERAPEUTICS INC position peaked at $8.11M in Q1 2018.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.